Blog
RSS FeedPosted by Michael Wonder on 05 Dec 2018
Generic drug prices ‘strongly predictive’ of shortages, study finds
4 December 2018 - How a generic drug is priced may be the difference between whether it experiences a shortage ...
Posted by Michael Wonder on 01 Dec 2018
‘A loss for the rest of us’: An FDA approval is a boon for a drug maker, but could come at a major cost for patients
30 November 2018 - Vickie Moored can walk again. Her words don’t slur, her vision isn’t blurred, and she no ...
Posted by Michael Wonder on 27 Nov 2018
FDA promised a ‘lower-cost option’ to EpiPen, but the price isn’t any lower
27 November 2018 - Teva's alternative to Mylan's authorised generic EpiPen is no cheaper. ...
Posted by Michael Wonder on 27 Nov 2018
Loxo and Bayer's amazing drug has an expensive price
26 November 2018 - A little more than a year ago, I wrote the story of a cancer drug developed by ...
Posted by Michael Wonder on 15 Nov 2018
Disclosing prescription-drug prices in advertisements — legal and public health issues
14 November 2018 - On October 15, 2018, the CMS proposed a rule requiring television advertisements for prescription drugs and ...
Posted by Michael Wonder on 14 Nov 2018
Pfizer launches epoetin alfa biosimilar, Retacrit, at 33.5% discount to reference Epogen
14 November 2018 - Pfizer announced today that it has launched its epoetin alfa biosimilar, Retacrit, at a substantial discount to ...
Posted by Michael Wonder on 12 Nov 2018
Drug prices on ads: as ‘relevant’ as percent daily value on food labels
9 November 2018 - President Trump announced late last month that his administration will push back on high drug costs ...
Posted by Michael Wonder on 09 Nov 2018
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
9 November 2018 - Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc’s infection-fighting treatment, ...
Posted by Michael Wonder on 25 Oct 2018
Pharmaceutical industry challenges Trump plan forcing companies to reveal drug prices in TV ads
25 October 2018 - Symbicort, an inhaler marketed to people whose lung disease makes them “huff and puff,” rolls off ...
Posted by Michael Wonder on 22 Oct 2018
Trump and his team fight for health consumers, starting with drug price transparency
22 October 2018 - Drugs like EpiPen have exorbitant prices due to price gouging. The Trump administration is taking steps to ...
Posted by Michael Wonder on 17 Oct 2018
J&J applauds U.S. proposal on drug prices in TV ads
16 October 2018 - Johnson & Johnson applauded a U.S. government proposal requiring drugmakers to include price of medicines in television ...
Posted by Michael Wonder on 16 Oct 2018
Drug price transparency won’t end the patent games
17 October 2018 - Just look at Humira, which is keeping its U.S. monopoly as generics hit the European market. ...
Posted by Michael Wonder on 27 Sep 2018
Trade deals aren't just for manufacturing, they can lower drug prices too
26 September 2018 - Moving forward, Trump should negotiate trade agreements that ensure other countries pay their fair share for the ...
Posted by Michael Wonder on 26 Sep 2018
Insulin prices could be much lower and drug makers would still make healthy profits
25 September 2018 - As prices for diabetes treatments continue to roil consumers, a new study suggests that manufacturers could ...
Posted by Michael Wonder on 26 Sep 2018
Big pharma boosts drug prices as supplies run low, study reveals
26 September 2018 - Federal lawmakers have been griping about drug pricing for years, led most recently by President Donald ...